Geneveve by Viveve is at the forefront of the booming demand for clinically proven women’s health and wellness treatments.
A new-generation treatment, Geneveve is a game changer in a market lacking clinically proven treatments in vaginal laxity. Currently used in many countries around the world, Geneveve treatment has benefitted thousands of women and improved their health and quality of life.
Geneveve, distributed in Australia by Device Consulting, is one of the biggest developments in women’s sexual health and function. It’s a 30-minute procedure with no downtime, designed to increase sexual response and tightness of the vagina.
The non-ablative, radiofrequency treatment works by targeting the vaginal introitus to rejuvenate collagen production, resulting in tightening and an increase in sensation.
The mechanism behind Geneveve by Viveve
Geneveve sets itself apart from existing vaginal laxity procedures as it requires a single session with a quick, simple protocol and it can be easily integrated into any practice. It works at a cellular level to restore and rebuild collagen without harming the vaginal opening.
Tissue tightening and strengthening, that is sustained up to 12 months and beyond, requires substantial heating and depth. Geneveve uses cryogen-cooled monopolar radiofrequency (CMRF) technology to deliver volumetric heating at precise temperatures, stimulating robust neocollagenesis and providing optimal structural support. The monopolar energy penetrates 3-5mm deep into connective tissue.
The reverse thermal gradient cools and protects the surface mucosa, while enabling significant heating of deep tissue. Capacitive coupling ensures energy is distributed evenly across the treatment tip for uniform heating, while parameters and algorithms are preset for reproducible delivery of controlled heating and cooling.
While other treatments are generally randomised, Geneveve by Viveve has a very replicable protocol and no learning curve. As such, doctors can have confidence knowing that whether they are performing the procedure themselves, or their nurses or other staff members are performing the procedure, it will be executed safely and will obtain consistently good results.
Introducing Geneveve by Viveve to your practice
While Geneveve presents a unique opportunity for gynaecologists, the biggest breakthrough is for doctors who provide cosmetic procedures but don’t yet treat the vagina.
Doctors introducing vaginal rejuvenation into their practices will be bringing a never-before approach to an underserved women’s health and wellness need.
Doctors using Geneveve will benefit from being an early adapter of the cryogen-cooled monopolar radiofrequency (CMRF) technology for neocollagenesis, as well as becoming a valuable resource for female sexual health. The conversation about women’s sexual health is timely and trending and there is very much an integral demand for a non-surgical low-risk/high-reward procedure.
In a recent survey of more than 400 women in the US who had vaginal deliveries, almost half of the women reported some level of concern with vaginal laxity. Most women notice that there’s a change after childbirth but they’re not quite sure how to define it. Geneveve is changing this.
Geneveve by Viveve is a giant step forward in improving sexual sensation and vaginal laxity, helping to revolutionise the landscape of women’s sexual health and wellness.
